{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T02:26:17Z","timestamp":1779157577372,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":3751,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.exphem.2011.11.005","type":"journal-article","created":{"date-parts":[[2011,11,23]],"date-time":"2011-11-23T14:08:44Z","timestamp":1322057324000},"page":"197-206.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["A subset of chronic lymphocytic leukemia patients display reduced levels of PARP1 expression coupled with a defective irradiation-induced apoptosis"],"prefix":"10.1016","volume":"40","author":[{"given":"Maria Giulia","family":"Bacalini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Tavolaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Peragine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilisa","family":"Marinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Santangelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Del Giudice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca Romana","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Di Maio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosaria","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Caiafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Chiaretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Fo\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Guarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Reale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2011.11.005_bib1","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM199510193331606","article-title":"Chronic lymphocytic leukemia","volume":"333","author":"Rozman","year":"1995","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.exphem.2011.11.005_bib2","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.005_bib3","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1182\/blood-2002-12-3639","article-title":"Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features","volume":"102","author":"Guarini","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.005_bib4","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.005_bib5","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMoa023143","article-title":"ZAP-70 expression as\u00a0a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia","volume":"348","author":"Crespo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2011.11.005_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2141.2005.05659.x","article-title":"The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience","volume":"130","author":"Gentile","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2011.11.005_bib7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa040857","article-title":"ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia","volume":"351","author":"Rassenti","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2011.11.005_bib8","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"Dohner","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2011.11.005_bib9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.1999.17.1.399","article-title":"B-cell chronic lymphocytic leukemia: a bird of a different feather","volume":"17","author":"Caligaris-Cappio","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2011.11.005_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00005-006-0019-x","article-title":"Modulation of apoptosis signaling for cancer therapy","volume":"54","author":"Fulda","year":"2006","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.exphem.2011.11.005_bib11","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.1140735","article-title":"An oncogene-induced DNA\u00a0damage model for cancer development","volume":"319","author":"Halazonetis","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.exphem.2011.11.005_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-1-4020-6554-5_5","article-title":"Therapeutic targeting of death pathways in cancer: mechanisms for activating cell death in cancer cells","volume":"615","author":"Tan","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.exphem.2011.11.005_bib13","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2004-11-4516","article-title":"Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL","volume":"106","author":"Austen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.005_bib14","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood-2003-09-3236","article-title":"Fludarabine treatment of\u00a0patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response","volume":"104","author":"Rosenwald","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.005_bib15","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2008-04-154070","article-title":"Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up","volume":"112","author":"Zenz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.005_bib16","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1182\/blood.V85.6.1580.bloodjournal8561580","article-title":"p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias","volume":"85","author":"Dohner","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.005_bib17","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1182\/blood.V100.4.1177.h81602001177_1177_1184","article-title":"Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors","volume":"100","author":"Oscier","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.005_bib18","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1182\/blood-2009-05-224071","article-title":"Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial","volume":"114","author":"Zenz","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.005_bib19","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood.V98.3.814","article-title":"p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation","volume":"98","author":"Pettitt","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.005_bib20","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm1963","article-title":"Poly(ADP-ribose): novel functions for an old molecule","volume":"7","author":"Schreiber","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.exphem.2011.11.005_bib21","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.2741\/2909","article-title":"The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases","volume":"13","author":"Hassa","year":"2008","journal-title":"Front Biosci"},{"issue":"Pt 2","key":"10.1016\/j.exphem.2011.11.005_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj3420249","article-title":"Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions","volume":"342","author":"D\u2019Amours","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.exphem.2011.11.005_bib23","doi-asserted-by":"crossref","first-page":"16441","DOI":"10.1074\/jbc.M608406200","article-title":"Ataxia telangiectasia mutated (ATM) signaling network is modulated by a novel poly(ADP-ribose)-dependent pathway in the early response to DNA-damaging agents","volume":"282","author":"Haince","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.exphem.2011.11.005_bib24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.molcel.2009.09.032","article-title":"A nuclear poly(ADP-ribose)-dependent signalosome confers DNA damage-induced IkappaB kinase activation","volume":"36","author":"Stilmann","year":"2009","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2011.11.005_bib25","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ncb1638","article-title":"Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation","volume":"9","author":"Kanai","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2011.11.005_bib26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.dnarep.2011.01.002","article-title":"Poly(ADP-ribosyl)ation affects stabilization of Che-1 protein in response to DNA damage","volume":"10","author":"Bacalini","year":"2011","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.exphem.2011.11.005_bib27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1139\/O07-062","article-title":"Che-1\/AATF, a multivalent adaptor connecting transcriptional regulation, checkpoint control, and apoptosis","volume":"85","author":"Passananti","year":"2007","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.exphem.2011.11.005_bib28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ccr.2006.10.012","article-title":"Che-1 phosphorylation by ATM\/ATR and Chk2 kinases activates p53 transcription and the G2\/M checkpoint","volume":"10","author":"Bruno","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2011.11.005_bib29","doi-asserted-by":"crossref","first-page":"19685","DOI":"10.1074\/jbc.M610282200","article-title":"The prolyl isomerase Pin1 affects Che-1 stability in response to apoptotic DNA damage","volume":"282","author":"De Nicola","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2011.11.005_bib30","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.194.11.1639","article-title":"Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia","volume":"194","author":"Rosenwald","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2011.11.005_bib31","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1084\/jem.194.11.1625","article-title":"Gene expression profiling of B\u00a0cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells","volume":"194","author":"Klein","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2011.11.005_bib32","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1200\/JCO.2009.23.4732","article-title":"Clinical utility of\u00a0microarray-based gene expression profiling in the diagnosis and\u00a0subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group","volume":"28","author":"Haferlach","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2011.11.005_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1073\/pnas.98.1.31","article-title":"Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection","volume":"98","author":"Li","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2011.11.005_bib34","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1158\/1078-0432.CCR-09-2534","article-title":"Aggressive chronic lymphocytic leukemia with elevated genomic complexity is associated with multiple gene defects in the response to DNA double-strand breaks","volume":"16","author":"Ouillette","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2011.11.005_bib35","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood-2005-12-5022","article-title":"Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia","volume":"108","author":"Rudd","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.005_bib36","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/modpathol.3800632","article-title":"Pathway-specific apoptotic gene expression profiling in chronic lymphocytic leukemia and follicular lymphoma","volume":"19","author":"Hui","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.exphem.2011.11.005_bib37","first-page":"27","article-title":"Poly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis","volume":"1552","author":"Tong","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.exphem.2011.11.005_bib38","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10565-008-9092-8","article-title":"Role of PARP-1 and PARP-2 in the expression of apoptosis-regulating genes in HeLa cells","volume":"25","author":"Cohausz","year":"2009","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.exphem.2011.11.005_bib39","doi-asserted-by":"crossref","first-page":"e1000428","DOI":"10.1371\/journal.pbio.1000428","article-title":"The BRCT domain of PARP-1 is required for immunoglobulin gene conversion","volume":"8","author":"Paddock","year":"2010","journal-title":"PLoS Biol"},{"key":"10.1016\/j.exphem.2011.11.005_bib40","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/1947601910383418","article-title":"Upregulation of poly (ADP-ribose) polymerase-1 (PARP1) in triple-negative breast cancer and other primary human tumor types","volume":"1","author":"Ossovskaya","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.exphem.2011.11.005_bib41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11010-006-9317-1","article-title":"Functional characterization of AATF transcriptome in human leukemic cells","volume":"297","author":"Kaul","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.exphem.2011.11.005_bib42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1128\/MCB.00704-08","article-title":"p53 chromatin epigenetic domain organization and p53 transcription","volume":"29","author":"Su","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2011.11.005_bib43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ccr.2010.05.027","article-title":"Che-1 promotes tumor cell survival by sustaining mutant p53 transcription and inhibiting DNA damage response activation","volume":"18","author":"Bruno","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2011.11.005_bib44","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1158\/1078-0432.CCR-08-1630","article-title":"The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness","volume":"15","author":"Rossi","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2011.11.005_bib45","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0092-8674(95)90541-3","article-title":"Yama\/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase","volume":"81","author":"Tewari","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2011.11.005_bib46","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1182\/blood-2010-01-265769","article-title":"The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in\u00a0vitro and in\u00a0vivo","volume":"116","author":"Weston","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.005_bib47","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood-2004-11-4296","article-title":"Decreased PARP and\u00a0procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia","volume":"106","author":"Holleman","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.11.005_bib48","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1128\/MCB.21.12.4046-4054.2001","article-title":"DNA strand break-sensing molecule poly(ADP-Ribose) polymerase cooperates with p53 in telomere function, chromosome stability, and tumor suppression","volume":"21","author":"Tong","year":"2001","journal-title":"Mol Cell Biol"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X11005789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X11005789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:29:10Z","timestamp":1759566550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X11005789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0301472X11005789"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2011.11.005","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A subset of chronic lymphocytic leukemia patients display reduced levels of PARP1 expression coupled with a defective irradiation-induced apoptosis","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2011.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}